325 related articles for article (PubMed ID: 31610782)
1. Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study.
Peng C; Lei P; Li X; Xie H; Yang X; Zhang T; Cao Z; Zhang J
Lipids Health Dis; 2019 Oct; 18(1):177. PubMed ID: 31610782
[TBL] [Abstract][Full Text] [Related]
2. Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.
Pérez-Belmonte LM; Moreno-Santos I; Cabrera-Bueno F; Sánchez-Espín G; Castellano D; Such M; Crespo-Leiro MG; Carrasco-Chinchilla F; Alonso-Pulpón L; López-Garrido M; Ruiz-Salas A; Becerra-Muñoz VM; Gómez-Doblas JJ; de Teresa-Galván E; Jiménez-Navarro M
Int J Med Sci; 2017; 14(3):268-274. PubMed ID: 28367087
[No Abstract] [Full Text] [Related]
3. Expression levels of miR-27a, miR-329, ABCA1, and ABCG1 genes in peripheral blood mononuclear cells and their correlation with serum levels of oxidative stress and hs-CRP in the patients with coronary artery disease.
Rafiei A; Ferns GA; Ahmadi R; Khaledifar A; Rahimzadeh-Fallah T; Mohmmad-Rezaei M; Emami S; Bagheri N
IUBMB Life; 2021 Jan; 73(1):223-237. PubMed ID: 33263223
[TBL] [Abstract][Full Text] [Related]
4. Methyl protodioscin increases ABCA1 expression and cholesterol efflux while inhibiting gene expressions for synthesis of cholesterol and triglycerides by suppressing SREBP transcription and microRNA 33a/b levels.
Ma W; Ding H; Gong X; Liu Z; Lin Y; Zhang Z; Lin G
Atherosclerosis; 2015 Apr; 239(2):566-70. PubMed ID: 25733328
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD).
Bhansali S; Yadav AK; Bakshi C; Dhawan V
Cardiovasc Drugs Ther; 2023 Aug; 37(4):667-682. PubMed ID: 35435604
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker.
Magenta A; Sileno S; D'Agostino M; Persiani F; Beji S; Paolini A; Camilli D; Platone A; Capogrossi MC; Furgiuele S
Clin Sci (Lond); 2018 Nov; 132(22):2423-2436. PubMed ID: 30389857
[TBL] [Abstract][Full Text] [Related]
8. miR-342-5p Expression Levels in Coronary Artery Disease Patients and its Association with Inflammatory Cytokines.
Ahmadi R; Heidarian E; Fadaei R; Moradi N; Malek M; Fallah S
Clin Lab; 2018 Apr; 64(4):603-609. PubMed ID: 29739089
[TBL] [Abstract][Full Text] [Related]
9. SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo.
Nishino T; Horie T; Baba O; Sowa N; Hanada R; Kuwabara Y; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Ide Y; Koyama S; Kimura M; Nagata M; Yoshida K; Takagi Y; Nakamura T; Hasegawa K; Miyamoto S; Kimura T; Ono K
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2460-2473. PubMed ID: 30354203
[TBL] [Abstract][Full Text] [Related]
10. MiR-126 on mice with coronary artery disease by targeting S1PR2.
Fan JL; Zhang L; Bo XH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):893-904. PubMed ID: 32016996
[TBL] [Abstract][Full Text] [Related]
11. Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs.
Li Y; Xu S; Jiang B; Cohen RA; Zang M
PLoS One; 2013; 8(6):e67532. PubMed ID: 23825667
[TBL] [Abstract][Full Text] [Related]
12. Lower Expression of miR-10a in Coronary Artery Disease and its Association with Pro/Anti-Inflammatory Cytokines.
Moradi N; Fadaei R; Ahmadi R; Kazemian E; Fallah S
Clin Lab; 2018 May; 64(5):847-854. PubMed ID: 29739060
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
Ding H; Hu CX; Xu JK
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.
Horie T; Nishino T; Baba O; Kuwabara Y; Nakao T; Nishiga M; Usami S; Izuhara M; Sowa N; Yahagi N; Shimano H; Matsumura S; Inoue K; Marusawa H; Nakamura T; Hasegawa K; Kume N; Yokode M; Kita T; Kimura T; Ono K
Nat Commun; 2013; 4():2883. PubMed ID: 24300912
[TBL] [Abstract][Full Text] [Related]
15. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Kivelä AM; Dijkstra MH; Heinonen SE; Gurzeler E; Jauhiainen S; Levonen AL; Ylä-Herttuala S
Atherosclerosis; 2012 Dec; 225(2):335-40. PubMed ID: 23102786
[TBL] [Abstract][Full Text] [Related]
16. The expression levels of miRNAs- 27a and 23a in the peripheral blood mononuclear cells (PBMCs) and their correlation with FOXO1 and some inflammatory and anti-inflammatory cytokines in the patients with coronary artery disease (CAD).
Babaee M; Chamani E; Ahmadi R; Bahreini E; Balouchnejadmojarad T; Nahrkhalaji AS; Fallah S
Life Sci; 2020 Sep; 256():117898. PubMed ID: 32522566
[TBL] [Abstract][Full Text] [Related]
17. Medicine. HDL miR-ed down by SREBP introns.
Brown MS; Ye J; Goldstein JL
Science; 2010 Jun; 328(5985):1495-6. PubMed ID: 20558698
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.
Yang M; Liu W; Pellicane C; Sahyoun C; Joseph BK; Gallo-Ebert C; Donigan M; Pandya D; Giordano C; Bata A; Nickels JT
J Lipid Res; 2014 Feb; 55(2):226-38. PubMed ID: 24296663
[TBL] [Abstract][Full Text] [Related]
19. Association between low levels of serum miR-638 and atherosclerotic plaque vulnerability in patients with high-grade carotid stenosis.
Luque A; Farwati A; Krupinski J; Aran JM
J Neurosurg; 2018 Jul; 131(1):72-79. PubMed ID: 30052155
[TBL] [Abstract][Full Text] [Related]
20. microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression.
Fitzsimons S; Oggero S; Bruen R; McCarthy C; Strowitzki MJ; Mahon NG; Ryan N; Brennan EP; Barry M; Perretti M; Belton O
Front Immunol; 2020; 11():576516. PubMed ID: 33391256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
